| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Sorrento Therapeutics, Inc. (SRNE) has 0 insiders with recent SEC Form 4 filings, including 9 buys and 0 sells. SRNE is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 26, 2015 | Ji Henry | President And CEO | Buy | 500 | $0.95 | $473.65 | +100.6% | |
| Aug 24, 2015 | Ji Henry | President And CEO | Buy | 8,888 | $12.84 | $114,148.58 | +100.0% | |
| Aug 21, 2015 | Ng George K | See Remarks | Buy | 888 | $13.50 | $11,989.52 | +66.6% | |
| Aug 21, 2015 | Ji Henry | President And CEO | Buy | 8,888 | $13.08 | $116,219.49 | +148.1% | |
| Aug 3, 2015 | Ng George K | See Remarks | Buy | 11,453 | $11.50 | $131,709.50 | +332.2% | |
| Aug 3, 2015 | Shah Jaisim | Director | Buy | 27,189 | $11.50 | $312,673.50 | +41.5% |